They Just Don't Get...
Health Care: Drugs
Javelin Pharmaceuticals Inc. (JAV: AMEX)
$2.20 0.00 | 0.00%
07/02/10 - 04:01 PM ET
222.68K / 2.08M
Vol / Avg. Vol:2.20 / 2.20
Open / Prev. Close:2.19 - 2.20
Today's Range:1.08 - 2.28
52 Wk Range:69.23%
Performance YTD:TheStreet Rating:
Portfolios with JAV
- Portfolio NameUser Type
- ContributorBarron's Activist Stocks 4-...
- ContributorBarron's Insider Purchases ...
- UserWilliam T Blanchard - Medical
- UserRet2009
- Usertony1pass1 Portfolio 1
- Userledmaiston Portfolio 1
- UserThatBobGuy Portfolio 1
- Userkro2003 Portfolio 1
- Userrimmekus
- Userssm Portfolio 1
Latest JAV Headlines from TheStreet
- Javelin Pharma, Spire: Volume Movers 06.29.10 | 07:06 am
- 13 Drugs Facing FDA Approval Decisions 06.16.10 | 07:06 am
- Hellenic Telecom, AspenBio Pharma: Midday Volume Plays 06.07.10 | 12:06 pm
- Javelin Pharmaceuticals, FuelCell Energy: Midday Volume Plays 06.03.10 | 01:06 pm
- The Five Dumbest Things on Wall Street: May 28 05.28.10 | 12:05 am
- Javelin Pharmeuticals, UQM Technologies: Midday Volume Plays 05.25.10 | 02:05 pm
- Global Sources, Hauppauge Digital: Midday Volume Plays 05.19.10 | 10:05 am
- 14 Biotech Stocks Facing FDA Approval 05.17.10 | 06:05 am
- Javelin Pharmaceuticals, EDAP: Early Volume Plays 04.12.10 | 10:04 am
- Illinois Tool Works Director Buys $442K Worth 02.17.10 | 09:02 am
Press Releases for JAV
- Javelin Pharmaceuticals, Inc. Announces Successful Completion Of Tender Offer For Its Common Stock By Hospira, Inc. - Business Wire 07.01.10 | 08:07 am
- Hospira Announces Successful Completion Of Tender Offer For Shares Of Javelin Pharmaceuticals - PR Newswire 07.01.10 | 08:07 am
- Hospira Announces Intention To Complete Tender Offer For Shares Of Javelin Pharmaceuticals - PR Newswire 06.28.10 | 07:06 pm
- News Release Service Inadvertently Issues Hoax Press Release Identifying Javelin Pharmaceuticals As Issuer - Business Wire 06.21.10 | 08:06 am
- Javelin Receives $2 Million Loan From Hospira - Business Wire 06.11.10 | 09:06 am
- Javelin Receives Notice From Hospira Of Funding Of Loan - Business Wire 06.07.10 | 08:06 am
- Javelin Receives Notice From NYSE Amex LLC Of Non-Compliance - Business Wire 06.04.10 | 04:06 pm
- Hospira Announces Further Extension Of Tender Offer For Shares Of Javelin Pharmaceuticals - PR Newswire 06.03.10 | 08:06 am
- Javelin Commences Litigation Against Hospira And Discus Acquisition Corporation, Asserts Hospira Is In Breach Of Merger Agreement And Specific Performance Provision Compels Completion Of Merger - Business Wire 06.03.10 | 07:06 am
- Javelin Pharmaceuticals, Inc. Provides Update To Dyloject™ UK Supply Chain - Business Wire 05.24.10 | 09:05 am
Partner Headlines for JAV
- A Peek Into The Market At The Start Of The Trading Day - Benzinga 07.01.10 | 09:07 am
- What Lies Ahead for Javelin Pharmaceuticals? - Seeking Alpha 06.06.10 | 04:06 am
- Hospira-Javelin Merger in Trouble - Analyst Blog - Zacks 06.04.10 | 03:06 pm
- Javelin (JAV) Slipped On Merger Concerns - Benzinga 06.03.10 | 01:06 pm
- UPDATE 1-Javelin sues Hospira alleging breach of merger deal - Reuters 06.03.10 | 08:06 am
- 6 Ways to Trade FDA and Clinical Trial News - Seeking Alpha 05.28.10 | 02:05 pm
- CORRECTED - CORRECTED-UPDATE 1-Javelin says batches of Dyloject to be withdr - Reuters 05.24.10 | 11:05 am
- Hospira Extends Javelin Offer - Analyst Blog - Zacks 05.20.10 | 01:05 pm
- FDA, Clinical Trial News: Discovery Labs, Hospira, Javelin Pharma - Seeking Alpha 05.20.10 | 06:05 am
- Hospira Surges Ahead (revised) - Analyst Blog - Zacks 04.27.10 | 05:04 pm
